Food and Drug Administration Commissioner Scott Gottlieb outlined a slew of policies, including restrictions on sales of flavored e-cigarettes, and essentially threatened to pull products from the market if manufacturers do not follow them.
The "Squawk Box" news team discusses some of the morning's most provocative headlines.
CNBC's Meg Tirrell reports on the new experimental depression drug seeking FDA approval.
CNBC's Meg Tirrell reports on Esperion shares heading higher on its new cholesterol drug. Esperion CEO and President Tim Mayleben joins 'Power Lunch' to discuss the new drug and drug pricing.
FDA Commissioner Scott Gottlieb speaks to "Squawk Box" about the Trump administration's plans for Medicare Part B prescription drug pricing.
CNBC's Meg Tirrell reports on the FDA set to review two new depression drugs and what it could mean for the pharma companies behind the drugs.
Doctor Scott Gottlieb, Food and Drug Administration commissioner, joins 'Squawk Box' to discuss the spike in e-cigarette usage.